If you’re facing liver cancer, Y90 radioembolization in Los Angeles offers renewed hope. This minimally invasive treatment safely delivers targeted radiation directly to liver tumors, sparing healthy tissue and helping you reclaim your life. With renowned interventional radiologists Dr. Gabriel Lipshutz and Dr. Jonathan Steinberger guiding your care, you can feel confident you’re receiving the most advanced treatment and compassionate support available.
Destroy liver cancer cells with targeted radiation
Y90 radioembolization is an advanced, minimally invasive procedure that precisely targets liver tumors. During the procedure, tiny beads infused with Yttrium-90, a radioactive substance, are carefully delivered through a small catheter into the blood vessels feeding the tumors. This destroys cancer cells while sparing surrounding healthy tissue, resulting in fewer side effects and quicker recovery. At DOCS Interventional Medicine, expert interventional radiologists Dr. Steinberger and Dr. Lipshutz use this innovative technique to effectively treat primary liver cancer and cancers that have spread to the liver.
What does Y90 radioembolization treat?
Y90 radioembolization in Los Angeles effectively treats primary liver cancer (hepatocellular carcinoma) and metastatic cancers that have spread to the liver, such as colon, breast, and pancreatic cancers. By selectively targeting and destroying tumors, this innovative procedure reduces the tumor burden, eases uncomfortable symptoms, and can improve your overall quality of life.
Under the specialized care of our interventional radiologists, Y90 radioembolization can help alleviate many symptoms commonly associated with liver tumors, including:
- Persistent abdominal pain or discomfort
- Unexplained weight loss or reduced appetite
- Fatigue and weakness
- Nausea and digestive issues
- Abdominal swelling or bloating
How does Y90 radioembolization work?
Y90 radioembolization works by delivering tiny radioactive beads directly into the liver tumors using precise imaging guidance. Our interventional radiologists insert a thin catheter into a small artery in your wrist or groin, gently guiding it through blood vessels to the liver. Once positioned, microscopic beads filled with radioactive Yttrium-90 (Y90) are released into the blood vessels supplying the tumor. These beads emit targeted radiation, shrinking tumors by destroying cancer cells from within while protecting surrounding healthy liver tissue.
Advantages of Y90 radioembolization:
- Minimally invasive procedure with fewer risks and complications
- Precisely targets liver tumors while sparing healthy tissue
- Often performed as an outpatient procedure with short recovery time
- Significantly reduces side effects compared to traditional radiation therapy
- Can shrink tumors, relieving pain and improving quality of life
- Suitable for patients who may not tolerate surgery or chemotherapy
- Can be repeated safely if needed for ongoing cancer control
What is recovery like after Y90 radioembolization?
After Y90 radioembolization, you can expect a relatively smooth recovery. Most patients go home the same day or after a short observation period. You may experience mild fatigue, nausea, or low-grade fever for a few days, but these symptoms resolve on their own. It’s important to rest, stay hydrated, and follow any post-procedure guidelines from your doctor. Over the next few weeks, the treatment continues working, shrinking tumors and relieving symptoms, helping you feel better and regain a sense of normalcy.
Schedule your consultation
DOCS Interventional Medicine is a leader in minimally invasive cancer treatments. With expertise honed over a decade at Cedars-Sinai, Dr. Steinberger and Dr. Lipshutz provide advanced, image-guided solutions such as Y90 radioembolization in Los Angeles to precisely target liver tumors while preserving healthy tissue. Our sophisticated yet compassionate approach ensures you receive expert care in a supportive environment. If you’re exploring treatment options for liver cancer, schedule your consultation today.
